A monoclonal antibody that is being studied in the treatment of adult T-cell leukemia and in the treatment of cytopenia (low blood cell count). Also called dacliximab.
(dә-kliz´u-mab) an immunosuppressant used to prevent acute organ rejection in renal transplant patients; administered intravenously.